Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ARR

Armour Residential REIT Monthly Update – August 2025

Armour Residential REIT, Inc. has released its monthly update for August 2025, providing a snapshot of key data as of July 31, 2025. The company's common stock price stood at $16.31, with a debt-equity ratio of 8.0 and implied leverage of 8.3. Total liquidity was reported at $850.4 million, representing 48% of total capital.

In terms of dividend information, the common dividend for August 2025 was $0.24, with the ex-dividend date/record date set at 08/15/2025 and the pay date on 08/29/2025.

The composition of Armour's portfolio as of 07/31/25 revealed that agency CMBS accounted for 4.5% of the portfolio, valued at $713.3 million. The majority of the portfolio comprised 30-year fixed-rate pools, making up 89.8% and valued at $14,240 million, with an effective duration using current values of 4.68.

In terms of repurchase composition, Buckler Securities LLC provided $7,143 million, representing 50.9% of repo positions with Armour, with a weighted average original term of 34 days and a weighted average remaining term of 13 days.

Armour's interest rate swaps maturity and notional amount showed varying figures across different time periods, with a total notional amount of $10,559 million and a weighted average remaining term of 58 months.

The detailed breakdown of the portfolio, repo composition, and interest rate swaps provides a comprehensive view of Armour Residential REIT, Inc.'s financial position and investment strategies as of the end of July 2025. Today the company's shares have moved -1.5% to a price of $15.06. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS